Refractory Endometrial Carcinoma
3 clinical trials · Condition
◉ Watch Refractory Endometrial Carcinoma
| Record | Firm | Date |
|---|---|---|
| IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors (NCT05039801) | M.D. Anderson Cancer Center | 2021-09-30 |
| Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer (NCT04719273) | Thomas Jefferson University | 2021-01-28 |
| A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma (NCT03008408) | M.D. Anderson Cancer Center | 2017-08-18 |
Track Refractory Endometrial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.